MRK DMA
As of date:10/19/2020
MRK stock price:78.67
MRK 50 DMA:82.88
MRK 200 DMA:79.94
MRK MACD (200-50):-2.94

Also see:
MRK Market Cap History
MRK Shares Outstanding History
MRK YTD Return
MRK RSI
MRK MACD
MRK Technical Analysis

Notable Two Hundred Day Moving Average Cross - EVLO
23 minutes ago


Voyager Therapeutics Breaks Below 200-Day Moving Average - Notable for VYGR
1 hour, 4 minutes ago


Bullish Two Hundred Day Moving Average Cross - PFLT
1 hour, 5 minutes ago


LNDC Makes Notable Cross Below Critical Moving Average
1 hour, 17 minutes ago


Newtek Business Services (NEWT) Shares Cross Below 200 DMA
1 hour, 18 minutes ago


AMGN Makes Notable Cross Below Critical Moving Average
1 hour, 23 minutes ago


ICU Medical (ICUI) Shares Cross Below 200 DMA
1 hour, 23 minutes ago


BOX Crosses Below Key Moving Average Level
1 hour, 31 minutes ago


Physicians Realty Trust (DOC) Shares Cross Below 200 DMA
1 hour, 33 minutes ago


Notable Two Hundred Day Moving Average Cross - EMD
1 hour, 37 minutes ago


Alexandria Real Estate Equities (ARE) Shares Cross Below 200 DMA
1 hour, 37 minutes ago


Notable Two Hundred Day Moving Average Cross - BWXT
1 hour, 38 minutes ago


FLR Crosses Above Key Moving Average Level
1 hour, 38 minutes ago


IIM Makes Notable Cross Below Critical Moving Average
1 hour, 38 minutes ago


Genpact Breaks Below 200-Day Moving Average - Notable for G
1 hour, 38 minutes ago


More Technical Analysis News

MRK DMAMRK MACD
Merck & Co. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Co.'s segments are: Pharmaceutical, which includes human health pharmaceutical products that consist of therapeutic and preventive agents for the treatment of human disorders, and human health vaccine products that consist of preventive pediatric, adolescent and adult vaccines; and Animal Health, which discovers, develops, manufactures and markets veterinary pharmaceuticals, vaccines and health management solutions and services, as well as a suite of digitally connected identification, traceability and monitoring products.

When researching a stock like Merck, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from MRK Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for MRK stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the MRK 200 day moving average ("MRK 200 DMA"), while one of the most popular "shorter look-backs" is the MRK 50 day moving average ("MRK 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Merck.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes
Get Free SEC filing alerts for MRK:
MRK SEC Filing Email Alerts ServiceExternal link
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Merck (MRK) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

MYL DMA
PFE DMA
PKI DMA
PRGO DMA
REGN DMA
RMD DMA
SYK DMA
TFX DMA
TMO DMA
UHS DMA
More Healthcare companies »

 

MRK DMA | www.StockDMA.com | Copyright © 2019 - 2020, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.